ArticleFrontiers in oncology2025
Predictors of lymph node metastasis in resectable pancreatic neuroendocrine neoplasms: a single-center retrospective study.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pancreatic neuroendocrine neoplasms (pNENs) present great heterogeneity in biological behavior, histological characteristics and clinical manifestations. Monocyte-to-lymphocyte ratio (MLR) is a noninvasive and easy-to-obtain indicator, that can reflect disease severity in multiple tumors. Lymph node metastasis (LNM) strongly affects the patient's surgical approach and prognosis. Predicting LNM before surgery has significance for the guidance of clinical treatment. We aimed to evaluate the predictive factors, including MLR associated with LNM of patients with resectable pNENs in our center. Methods: A total of 64 patients who underwent pNEN resection and lymph node dissection in our hospital from July 2014 until June 2023 were included in this study. Univariate and multivariate analyses were performed to identify predictive factors for LNM by analyzing clinical data, inflammatory markers, and pathological features. Results: Among the 64 patients, 15 (23.4%) were node positive. Univariate analysis revealed that vascular invasion, peripheral nerve invasion, bilirubin level, tumor grade, tumor size and MLR (p<0.05 for all) were risk factors for LNM. Multivariate logistic analysis demonstrated that tumor size was the only independent risk factor for LNM in our study. Multivariate ROC analysis had better predictive performance than univariate analysis did. Conclusions: The preoperative MLR, vascular invasion, peripheral nerve invasion, bilirubin level, tumor grade and tumor size are potential predictors of LNM, especially during the initial diagnosis of resectable pNENs. Multivariate ROC analysis demonstrated superior performance by incorporating variables significant in univariate analysis. These factors combined can assist in clinical decision-making, such as more aggressive early intervention or intensive follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.